070429249	070429249	CD	B-NP	O
|	|	NN	I-NP	O
EAVH	EAVH	NN	I-NP	O
|	|	NN	I-NP	O
66367206	66367206	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6946838	6946838	CD	B-NP	O
|	|	CC	I-NP	O
4/30/2006	4/30/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Back	Back	RB	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
12/10/2006	12/10/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/9/2006	9/9/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
EBERLEIN	EBERLEIN	NN	I-NP	O
,	,	,	O	O
CHRISTOPER	CHRISTOPER	NNP	B-NP	O
705-04-21-4	705-04-21-4	CD	I-NP	O
Rama	Rama	NNP	I-NP	O
Ry	Ry	NNP	I-NP	O
Clark	Clark	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/17/06	7/17/06	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
STAINO	STAINO	NNP	B-NP	O
,	,	,	O	O
MICHAL	MICHAL	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
TIAZAC	TIAZAC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
EXTENDED	EXTENDED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
360	360	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/9/06	8/9/06	CD	B-NP	O
by	by	IN	B-PP	O
CUNAS	CUNAS	NNP	B-NP	O
,	,	,	O	O
PETER	PETER	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
BENADRYL	BENADRYL	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
DIPHENHYDRAMINE	DIPHENHYDRAMINE	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q6H	Q6H	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
Itching	Itch	VBG	B-VP	I-protein
DISOPYRAMIDE-CONTROLLED	DISOPYRAMIDE-CONTROLLED	JJ	B-NP	I-protein
RELEASE	RELEASE	NN	I-NP	I-protein
300	300	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
NEXIUM	NEXIUM	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
TENEX	TENEX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GUANFACINE	GUANFACINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HYDROXYZINE	HYDROXYZINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9	9	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
50	50	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LACTULOSE	LACTULOSE	NNP	I-NP	O
30	30	CD	I-NP	O
MILLILITERS	MILLILITERS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
LEVOXYL	LEVOXYL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
200	200	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/17/06	10/17/06	CD	B-NP	O
by	by	IN	B-PP	O
CARTHER	CARTHER	NN	B-NP	O
,	,	,	O	O
JULIUS	JULIUS	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/9/06	8/9/06	CD	B-NP	O
by	by	IN	B-PP	O
COULTAS	COULTAS	NNP	B-NP	O
,	,	,	O	O
HERB	HERB	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TIAZAC	TIAZAC	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
266923889	266923889	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
OXYCODONE	OXYCODONE	NN	I-NP	O
5-10	5-10	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
OXYCONTIN	OXYCONTIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OXYCODONE	OXYCODONE	NNP	I-NP	O
CONTROLLED	CONTROLLED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q12H	Q12H	NN	I-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
TOPAMAX	TOPAMAX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
TOPIRAMATE	TOPIRAMATE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
125	125	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
ZOMETA	ZOMETA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ZOLEDRONIC	ZOLEDRONIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
2	2	CD	B-NP	O
MG	MG	NN	I-NP	O
IV	IV	CD	B-NP	O
Monthly	Monthly	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Benoist	Benoist	NNP	I-NP	O
,	,	,	O	O
AH	AH	NNP	B-NP	O
4/12	4/12	CD	I-NP	O
@	@	NN	I-NP	O
3pm	3pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Back	Back	NN	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Back	Back	NNP	I-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
h/o	h/o	NN	I-NP	O
PAF	PAF	NN	I-NP	B-protein
converted	convert	VBN	B-VP	O
with	with	IN	B-PP	O
nad	nad	NN	B-NP	O
s/p	s/p	NN	I-NP	O
TAH/BSO	TAH/BSO	NN	I-NP	O
s/p	s/p	NN	I-NP	O
colectomy/stoma/rversal	colectomy/stoma/rversal	NN	I-NP	O
DM	DM	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
MRI	MRI	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Back	Back	NN	B-NP	O
pain	pain	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
61	61	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
IgA	IgA	NN	B-NP	B-protein
lambda	lambda	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
myeloma	myeloma	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
R	R	NN	I-NP	O
lumbar	lumbar	NN	I-NP	O
pain	pain	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

Distribution	Distribution	NN	B-NP	O
same	same	JJ	B-ADJP	O
,	,	,	O	O
intensity	intensity	NN	B-NP	O
worse	worse	JJR	B-ADJP	O
;	;	:	O	O
constant	constant	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
DOA	DOA	NN	B-NP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate/bear	ambulate/bear	VB	I-VP	O
weight	weight	NN	B-NP	O
,	,	,	O	O
limiting	limit	VBG	B-VP	O
ability	ability	NN	B-NP	O
to	to	TO	B-VP	O
care	care	VB	I-VP	O
for	for	IN	B-PP	O
herself	herself	PRP	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
trauma	trauma	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
neuro	neuro	NN	I-NP	O
deficits	deficit	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
incontinence	incontinence	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
given	give	VBN	B-PP	O
MSO4	MSO4	NN	B-NP	B-protein
,	,	,	O	O
valium	valium	NN	B-NP	O
,	,	,	O	O
benadryl	benadryl	NN	B-NP	O
ROS	ROS	NNS	I-NP	O
:	:	:	O	O
reports	report	NNS	B-NP	O
qd	qd	VBP	B-VP	O
temp	temp	NN	B-NP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
sweats	sweat	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
localizing	localize	VBG	I-NP	O
sx	sx	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
wt	wt	NN	I-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
appetite	appetite	NN	I-NP	O
.	.	.	O	O

B/l	B/l	NN	B-NP	O
forearm	forearm	NN	I-NP	O
pruritic	pruritic	JJ	I-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
worse	worse	JJR	B-ADJP	O
than	than	IN	B-PP	O
baseline	baseline	NN	B-NP	O
annual	annual	JJ	I-NP	O
sun-exposure	sun-exposure	NN	I-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
MM	MM	NN	B-NP	O
with	with	IN	B-PP	O
IgA	IgA	NN	B-NP	B-protein
lambda	lambda	NN	I-NP	I-protein
,	,	,	O	O
sz	sz	NN	B-NP	O
d/o	d/o	NN	I-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
****	****	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
norpace	norpace	NN	B-NP	O
,	,	,	O	O
dilt	dilt	NN	B-NP	O
,	,	,	O	O
toprol	toprol	NN	B-NP	O
,	,	,	O	O
tenex	tenex	NN	B-NP	O
,	,	,	O	O
aranesp	aranesp	NN	B-NP	O
,	,	,	O	O
topamax	topamax	NN	B-NP	O
,	,	,	O	O
levoxyl	levoxyl	NN	B-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
50	50	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
ISS	ISS	NN	B-NP	B-protein
,	,	,	O	O
zometa	zometa	NN	B-NP	O
qmo	qmo	NN	I-NP	O
****	****	SYM	B-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
96.4	96.4	CD	B-NP	O
89146/73	89146/73	CD	I-NP	O
18	18	CD	I-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

A+O	A+O	NN	B-NP	B-protein
x3	x3	NN	I-NP	I-protein
,	,	,	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
obese	obese	NN	B-NP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
abd	abd	NN	B-NP	O
soft	soft	JJ	I-NP	O
w/baseline	w/baseline	NN	I-NP	O
RLQ	RLQ	NN	I-NP	O
ttp	ttp	NN	I-NP	O
,	,	,	O	O
mult	mult	JJ	B-NP	O
scars	scar	NNS	I-NP	O
,	,	,	O	O
NABS	NABS	NNP	B-NP	O
,	,	,	O	O
guaiac	guaiac	JJ	B-NP	O
neg	neg	NN	I-NP	O
with	with	IN	B-PP	O
nl	nl	NN	B-NP	O
tone	tone	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
neuro	neuro	NN	I-NP	O
deficits	deficit	VBZ	B-VP	O
with	with	IN	B-PP	O
4/5	4/5	CD	B-NP	O
plantar	plantar	NN	I-NP	O
flexor	flexor	NN	I-NP	O
and	and	CC	O	O
hip	hip	NN	B-NP	O
flexor	flexor	NN	I-NP	O
on	on	IN	B-PP	O
R	R	NN	B-NP	B-protein
,	,	,	O	O
toes	toe	VBZ	B-VP	O
equiv	equiv	NN	B-NP	O
,	,	,	O	O
DTRs	DTR	NNS	B-NP	B-protein
1	1	CD	I-NP	I-protein
+	+	SYM	I-NP	O
b/l	b/l	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
bony	bony	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
ttp	ttp	NN	I-NP	O
over	over	IN	B-PP	O
R	R	NN	B-NP	O
lat	lat	JJ	I-NP	O
paraspinal	paraspinal	JJ	I-NP	O
musculature	musculature	NN	I-NP	O
.	.	.	O	O

Neg	Neg	NN	B-NP	O
straight	straight	JJ	I-NP	O
leg	leg	NN	I-NP	O
raise	raise	NN	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	B-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
K	K	NN	B-NP	O
3.5	3.5	CD	I-NP	O
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
UA	UA	NNP	B-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
Bld	Bld	NNP	B-NP	O
Cx	Cx	NNP	I-NP	O
neg	neg	NN	I-NP	O
STUDIES	STUDIES	NN	I-NP	O
:	:	:	O	O
pelvis	pelvis	NN	B-NP	O
and	and	CC	I-NP	O
L	L	NN	I-NP	O
spine	spine	NN	I-NP	O
:	:	:	O	O
mild	mild	JJ	B-NP	O
L5-S1	L5-S1	NN	I-NP	O
disc	disc	NN	I-NP	O
space	space	NN	I-NP	O
narrowing	narrowing	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
compression	compression	NN	I-NP	O
fx	fx	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lytic	lytic	JJ	I-NP	O
or	or	CC	I-NP	O
blastic	blastic	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
MRI	MRI	NN	I-NP	O
:	:	:	O	O
prelim	prelim	NN	B-NP	O
read	read	NN	I-NP	O
,	,	,	O	O
L4-5	L4-5	NN	B-NP	O
disc	disc	NN	I-NP	O
bulging	bulge	VBG	B-VP	O
with	with	IN	B-PP	O
local	local	JJ	B-NP	O
nerve	nerve	NN	I-NP	O
root	root	NN	I-NP	O
compression	compression	NN	I-NP	O
,	,	,	O	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
heterogeneity	heterogeneity	NN	I-NP	O
as	as	RB	B-ADVP	O
previously	previously	RB	I-ADVP	O
on	on	IN	B-PP	O
MRI	MRI	NN	B-NP	B-DNA
8/3	8/3	CD	I-NP	I-DNA
****	****	SYM	I-NP	O
A	A	NN	I-NP	O
:	:	:	O	O
61	61	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
MM	MM	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
R	R	NN	I-NP	O
lumbar	lumbar	NN	I-NP	O
pain	pain	NN	I-NP	O
here	here	RB	B-ADVP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
pain	pain	NN	B-NP	O
limiting	limit	VBG	B-VP	O
ADLs	ADL	NNS	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Started	Start	VBD	B-VP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
oxycontin	oxycontin	NN	I-NP	O
bid	bid	NN	I-NP	O
with	with	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
for	for	IN	B-PP	O
breakthrough	breakthrough	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
to	to	TO	B-VP	O
suggest	suggest	VB	I-VP	O
lesion	lesion	NN	B-NP	O
2/2	2/2	CD	I-NP	O
MM	MM	NN	I-NP	O
.	.	.	O	O

F/u	F/u	NN	B-NP	O
final	final	JJ	I-NP	O
MRI	MRI	NN	I-NP	O
read	read	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
needs	need	VBZ	B-VP	O
trial	trial	NN	B-NP	O
of	of	IN	B-PP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
,	,	,	O	O
outpatient	outpatient	NN	B-NP	O
PT	PT	NN	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Pain	Pain	NNP	B-NP	O
and/or	and/or	CC	O	O
Neurosurgical	Neurosurgical	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
if	if	IN	B-SBAR	O
still	still	RB	B-ADJP	O
symptomatic	symptomatic	JJ	I-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

HEME/ONC	HEME/ONC	NN	B-NP	O
:	:	:	O	O
IgA	IgA	NN	B-NP	B-protein
pending	pending	NN	I-NP	O
,	,	,	O	O
f/u	f/u	NN	B-NP	O
at	at	IN	B-PP	O
GH	GH	NN	B-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
for	for	IN	B-PP	O
Zometa	Zometa	NNP	B-NP	O
4/12	4/12	CD	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Continued	Continue	VBN	B-VP	O
extensive	extensive	JJ	B-NP	O
list	list	NN	I-NP	O
of	of	IN	B-PP	O
home	home	NN	B-NP	B-protein
antihypertensive	antihypertensive	JJ	I-NP	I-protein
medications	medication	NNS	I-NP	I-protein
4	4	CD	B-NP	I-protein
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
Continued	Continue	VBN	B-NP	O
home	home	NN	I-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
A1c	A1c	NN	B-NP	O
pending	pending	NN	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
low	low	JJ	B-ADJP	O
at	at	IN	B-PP	O
0.174	0.174	CD	B-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
adjusted	adjusted	JJ	B-NP	O
Levoxyl	Levoxyl	NN	I-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
source	source	NN	I-NP	O
for	for	IN	B-PP	O
fevers	fever	NNS	B-NP	O
aside	aside	RB	B-ADVP	O
from	from	IN	B-PP	O
MM	MM	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
source	source	NN	I-NP	O
identified	identify	VBN	B-VP	O
on	on	IN	B-PP	O
MRI	MRI	NNP	B-NP	O
,	,	,	O	O
UA/Cx	UA/Cx	NNP	B-NP	O
or	or	CC	O	O
Bld	Bld	NNP	B-NP	O
Cx	Cx	NNP	I-NP	O
.	.	.	O	O

Afebrile	Afebrile	IN	B-PP	O
here	here	RB	B-NP	O
,	,	,	O	O
unclear	unclear	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
this	this	DT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
neoplastic	neoplastic	JJ	B-NP	O
versus	versus	CC	I-NP	O
thermometer	thermometer	NN	I-NP	O
error	error	NN	I-NP	O
versus	versus	CC	B-NP	O
operator	operator	NN	I-NP	O
error	error	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

DERM	DERM	NN	B-NP	O
:	:	:	O	O
Pruritic	Pruritic	JJ	B-NP	O
papular	papular	JJ	I-NP	O
rash	rash	NN	I-NP	O
over	over	IN	B-PP	O
b/l	b/l	NN	B-NP	O
upper	upper	JJ	I-NP	O
arms	arm	NNS	I-NP	O
,	,	,	O	O
somewhat	somewhat	RB	B-ADVP	O
like	like	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
annual	annual	JJ	I-NP	O
sun-associated	sun-associated	JJ	I-NP	O
allergy	allergy	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-NP	O
atarax	atarax	NN	I-NP	O
,	,	,	O	O
benedryl	benedryl	NN	B-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Seek	Seek	VB	B-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
notice	notice	VBP	B-VP	O
weakness	weakness	NN	B-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
problems	problem	NNS	B-NP	O
with	with	IN	B-PP	O
bowel	bowel	NN	B-NP	O
or	or	CC	I-NP	O
bladder	bladder	NN	I-NP	O
incontinence	incontinence	NN	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
pain	pain	NN	I-NP	O
medications	medication	NNS	I-NP	O
can	can	MD	B-VP	O
cause	cause	VB	I-VP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
use	use	VBP	B-VP	O
the	the	DT	B-NP	O
provided	provide	VBN	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
this	this	DT	B-NP	O
side	side	NN	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

F/U	F/U	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bulkley	Bulkley	NNP	I-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
IgA	IgA	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
Pain	Pain	NNP	B-NP	O
or	or	CC	I-NP	O
Neurosurgery	Neurosurgery	NNP	I-NP	O
evaluation	evaluation	NN	I-NP	O
if	if	IN	B-SBAR	O
pain	pain	NN	B-NP	O
not	not	RB	O	O
control	control	VB	B-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
medications	medication	NNS	I-NP	I-protein
3	3	CD	B-NP	I-protein
.	.	.	O	O

F/U	F/U	NN	B-NP	O
A1c	A1c	NN	I-NP	O
,	,	,	O	O
pending	pende	VBG	B-PP	O
4	4	CD	B-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
Levoxyl	Levoxyl	NN	B-NP	O
dose	dose	NN	I-NP	O
given	give	VBN	B-VP	O
low	low	JJ	B-NP	O
TSH	TSH	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
FELKEL	FELKEL	NNP	B-NP	O
,	,	,	O	O
DWIGHT	DWIGHT	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
QO80	QO80	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/17/06	7/17/06	CD	I-NP	O
@	@	NN	I-NP	O
09	09	CD	I-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

